BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30551478)

  • 21. PHF6 mutations in T-lineage acute lymphoblastic leukemia.
    Holmfeldt L; Mullighan CG
    Pediatr Blood Cancer; 2010 Oct; 55(4):595-6. PubMed ID: 20589626
    [No Abstract]   [Full Text] [Related]  

  • 22. PHF6 functions as a tumor suppressor by recruiting methyltransferase SUV39H1 to nucleolar region and offers a novel therapeutic target for PHF6-muntant leukemia.
    Tsai HI; Wu Y; Huang R; Su D; Wu Y; Liu X; Wang L; Xu Z; Pang Y; Sun C; He C; Shu F; Zhu H; Wang D; Cheng F; Huang L; Chen H
    Acta Pharm Sin B; 2022 Apr; 12(4):1913-1927. PubMed ID: 35847518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of Börjeson-Forssman-Lehmann syndrome: Insights from PHF6 function.
    Jahani-Asl A; Cheng C; Zhang C; Bonni A
    Neurobiol Dis; 2016 Dec; 96():227-235. PubMed ID: 27633282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PHF6 and JAK3 mutations cooperate to drive T-cell acute lymphoblastic leukemia progression.
    Yuan S; Wang X; Hou S; Guo T; Lan Y; Yang S; Zhao F; Gao J; Wang Y; Chu Y; Shi J; Cheng T; Yuan W
    Leukemia; 2022 Feb; 36(2):370-382. PubMed ID: 34465864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A nelarabine-resistant T-lymphoblastic leukemia CCRF-CEM variant cell line is cross-resistant to the purine nucleoside phosphorylase inhibitor forodesine.
    Yamauchi T; Uzui K; Nishi R; Tasaki T; Ueda T
    Anticancer Res; 2014 Sep; 34(9):4885-92. PubMed ID: 25202070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression?
    Kawashima-Goto S; Imamura T; Tomoyasu C; Yano M; Yoshida H; Fujiki A; Tamura S; Osone S; Ishida H; Morimoto A; Kuroda H; Hosoi H
    PLoS One; 2015; 10(7):e0132926. PubMed ID: 26172269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells.
    Paugh SW; Bonten EJ; Savic D; Ramsey LB; Thierfelder WE; Gurung P; Malireddi RK; Actis M; Mayasundari A; Min J; Coss DR; Laudermilk LT; Panetta JC; McCorkle JR; Fan Y; Crews KR; Stocco G; Wilkinson MR; Ferreira AM; Cheng C; Yang W; Karol SE; Fernandez CA; Diouf B; Smith C; Hicks JK; Zanut A; Giordanengo A; Crona D; Bianchi JJ; Holmfeldt L; Mullighan CG; den Boer ML; Pieters R; Jeha S; Dunwell TL; Latif F; Bhojwani D; Carroll WL; Pui CH; Myers RM; Guy RK; Kanneganti TD; Relling MV; Evans WE
    Nat Genet; 2015 Jun; 47(6):607-14. PubMed ID: 25938942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ex vivo modulation of response to prednisolone in childhood acute lymphoblastic leukaemia.
    Styczynski J; Wysocki M
    Br J Haematol; 2006 May; 133(4):397-9. PubMed ID: 16643446
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Wendorff AA; Quinn SA; Rashkovan M; Madubata CJ; Ambesi-Impiombato A; Litzow MR; Tallman MS; Paietta E; Paganin M; Basso G; Gastier-Foster JM; Loh ML; Rabadan R; Van Vlierberghe P; Ferrando AA
    Cancer Discov; 2019 Mar; 9(3):436-451. PubMed ID: 30567843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PHF6 interacts with the nucleosome remodeling and deacetylation (NuRD) complex.
    Todd MA; Picketts DJ
    J Proteome Res; 2012 Aug; 11(8):4326-37. PubMed ID: 22720776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Börjeson-Forssman-Lehmann Syndrome due to a novel plant homeodomain zinc finger mutation in the PHF6 gene.
    Mangelsdorf M; Chevrier E; Mustonen A; Picketts DJ
    J Child Neurol; 2009 May; 24(5):610-4. PubMed ID: 19264739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro resistance of leukaemic blasts to prednisolone in bcr-abl positive childhood acute lymphoblastic leukaemia.
    Gupta M; Kumar A; Dabadghao S
    Indian J Med Res; 2002 Dec; 116():268-72. PubMed ID: 12807155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin E2 induces growth inhibition, apoptosis and differentiation in T and B cell-derived acute lymphoblastic leukemia cell lines (CCRF-CEM and Nalm-6).
    Soleymani Fard S; Jeddi Tehrani M; Ardekani AM
    Prostaglandins Leukot Essent Fatty Acids; 2012 Jul; 87(1):17-24. PubMed ID: 22749740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.
    Kaspers GJ; Pieters R; Van Zantwijk CH; Van Wering ER; Van Der Does-Van Den Berg A; Veerman AJ
    Blood; 1998 Jul; 92(1):259-66. PubMed ID: 9639525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Tissue Transglutaminase on Steroid Resistance in T-Cell Acute Lymphoblastic Leukemia.
    Jung HJ; Han EH; Jang IK; Yoon SH; Park JE
    Anticancer Res; 2019 Nov; 39(11):6165-6173. PubMed ID: 31704844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of hypoxia on proliferation and glucocorticoid resistance of T-cell acute lymphoblastic leukaemia.
    Li Y; Wei Y; Gu L
    Hematology; 2021 Dec; 26(1):775-784. PubMed ID: 34565306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexistence of EZH2, NOTCH1, IL7R, and PHF6 Mutations in Adult T-cell Acute Lymphoblastic Leukemia.
    Zhou X; Gu Y; Han Q; Soliman M; Song C; Ge Z
    Turk J Haematol; 2017 Dec; 34(4):366-368. PubMed ID: 28747286
    [No Abstract]   [Full Text] [Related]  

  • 38. A new face of Borjeson-Forssman-Lehmann syndrome? De novo mutations in PHF6 in seven females with a distinct phenotype.
    Zweier C; Kraus C; Brueton L; Cole T; Degenhardt F; Engels H; Gillessen-Kaesbach G; Graul-Neumann L; Horn D; Hoyer J; Just W; Rauch A; Reis A; Wollnik B; Zeschnigk M; Lüdecke HJ; Wieczorek D
    J Med Genet; 2013 Dec; 50(12):838-47. PubMed ID: 24092917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A copper chelate induces apoptosis and overcomes multidrug resistance in T-cell acute lymphoblastic leukemia through redox imbalance and inhibition of EGFR/PI3K/Akt expression.
    Banerjee K; Das S; Sarkar A; Chatterjee M; Biswas J; Choudhuri SK
    Biomed Pharmacother; 2016 Dec; 84():71-92. PubMed ID: 27639544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation screening in Borjeson-Forssman-Lehmann syndrome: identification of a novel de novo PHF6 mutation in a female patient.
    Crawford J; Lower KM; Hennekam RC; Van Esch H; Mégarbané A; Lynch SA; Turner G; Gécz J
    J Med Genet; 2006 Mar; 43(3):238-43. PubMed ID: 15994862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.